Comparison

GW441756 hydrochloride European Partner

Item no. ALO-G-191-5mg
Manufacturer Alomone
CASRN 504433-24-3
Amount 5 mg
Quantity options 10 mg 25 mg 50 mg 5 mg
Category
Type Small Molecules
Format Lyophilized
Specific against other
Purity ≥97%
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Room temperature
Available
Manufacturer - Type
Non Antibodies
Manufacturer - Category
S. Molecules
Manufacturer - Targets
TrkA receptors
Country of Origin
Israel
Shipping Temperature
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Storage Conditions
Storage as Solution: Up to four weeks at 4°C or three months at -20°C. - Storage after Reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods (up to 6 months), small aliquots should be stored at -20°C. We do not recommend storing the product in working solutions for longer than a few days. Avoid multiple freeze-thaw cycles.
Molecular Weight
311, 8
Manufacturer - Format
Lyophilized powder.
Short description
A Potent Inhibitor of TrkA
Description
A Potent Inhibitor of TrkA
Reconstitution
4-10 mM in H2O. Centrifuge all product preparations before use (5, 000 x g for 1 min).
PH
7, 4
UNSPSC
41116134
Effective Concentration
2 nM - 2 µM.
Activity
GW441756 is a potent, selective inhibitor of the NGF receptor tyrosine kinase A (TrkA)1.
Solubility
4-10 mM in H2O. Centrifuge all product preparations before use (5, 000 x g for 1 min).
Bioassay tested
Yes
Chemical Name
(3Z)-3-[(1-methylindol-3-yl)methylidene]-1H-pyrrolo[3, 2-b]pyridin-2-one; hydrochloride.
Scientific Background
GW441756 is a potent and selective inhibitor of the NGF receptor tyrosine kinase A (TrkA). This compound also inhibits TrkB and TrkC but displays significantly higher selectivity for TrkA receptor than other TrkA inhibitors and a 100-fold selectivity over a range of other kinases. The IC50 value of GW441756 is 2 nM1, 3.The compound induces a dose-dependent decrease in neoplastic proliferation and has the ability to increase levels of caspase-3 that can lead to apoptosis.Previous studies have shown that TrKA inhibitors have a relevant anti-proliferative effects in neoplasia compare to other TrkA inhibitors with a lower effective dosage1, 3.Signaling through protein tyrosine kinase receptors is important for neuronal metabolism, promotion of neuronal survival, stimulating neurite growth, synaptogenesis and potentiating synaptic strength2.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close